~~<i id='6B374DB290'><strike id='6B374DB290'><tt id='6B374DB290'><pre id='6B374DB290'></pre></tt></strike></i>~~

Home» comprehensive» focus

focus

author：comprehensive 2025-09-06 05:20:38 Page View：8

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： STAT Virtual Event: JPM Recap, Live!
Next article： The high cost of giving birth even with insurance

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

At JPM 2024, hospital systems pitch financial strength to investors

AdobeSANFRANCISCO—HospitalleadersspentagoodchunkoftheirstagetimeattheJ.P.MorganHealthcareConferencet

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Profiling embryos to choose those with higher IQs is almost a reality

AdobeWhenHeJiankuiannouncedthathehad“edited”twoembryosinhopesofensuringtheywouldbecomeimmunetothevir

WSS

focus

focus

leisure time

Wikipedia

Profiling embryos to choose those with higher IQs is almost a reality